Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132546) titled 'Locally Advanced Squamous Cell Carcinoma of the Head and Neck in the Elderly: A Prospective Phase II Study of Nimotuzumab Plus Radiotherapy' on Sept. 15.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Peking Union Medical College Hospital
Condition:
Head and neck carcinoma
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-09-22
Target Sample Size: Experimental group:46;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=341937
Published by HT Digital Content Services with permission from Health Dail...